Koers Hypertension Diagnostics, Inc. Other OTC
Aandelen
HDII
US44914V1044
Geavanceerde medische apparatuur & technologie
Omzet 2017 | 3,68 mln. 3,43 mln. | Omzet 2018 | 3,79 mln. 3,54 mln. | Marktkapitalisatie | 92,08K 85,9K |
---|---|---|---|---|---|
Nettowinst (verlies) 2017 | - 0 | Nettowinst (verlies) 2018 | - 0 | EV/omzet 2017 | 1,15 x |
Nettoschuld 2017 | 4,13 mln. 3,85 mln. | Nettoschuld 2018 | 4,6 mln. 4,29 mln. | EV/omzet 2018 | 1,24 x |
K/w-verhouding 2017 |
-0,28
x | K/w-verhouding 2018 |
-0,54
x | Werknemers | - |
Dividendrendement 2017 * |
-
| Dividendrendement 2018 |
-
| Vrij verhandelbaar | 100% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Liangjian Peng
CEO | Chief Executive Officer | - | - |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Liangjian Peng
CEO | Chief Executive Officer | - | - |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+2,06% | 207 mld. | |
+5,69% | 181 mld. | |
+29,31% | 155 mld. | |
+1,90% | 64,42 mld. | |
+18,36% | 54,38 mld. | |
-1,92% | 47,43 mld. | |
-8,37% | 37,17 mld. | |
-1,37% | 34,81 mld. | |
+8,67% | 27,46 mld. |